2024 |
Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren's syndrome |
Articolo in rivista |
Vai |
2023 |
The Role of Neutrophils in Spondyloarthritis: A Journey across the Spectrum of Disease Manifestations |
Review essay (rassegna critica) |
Vai |
2023 |
The potential relationship between PU.1 and IL-9 in the development of arthritis |
Lettera |
Vai |
2023 |
JAK/STAT inhibition modifies the ILC1 immune response in patients with rheumatoid arthritis |
Articolo in rivista |
Vai |
2023 |
Successful treatment of eosinophilic fasciitis with the anti-IL5 receptor monoclonal antibody benralizumab |
Lettera |
Vai |
2023 |
Rituximab-induced hypogammaglobulinaemia in patients affected by idiopathic inflammatory myopathies: a multicentre study |
Articolo in rivista |
Vai |
2023 |
Characterising oesophageal motility disorders by high-resolution impedance manometry in dermatomyositis patients |
Articolo in rivista |
Vai |
2023 |
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review |
Review essay (rassegna critica) |
Vai |
2022 |
Metabolic Reprogramming of Innate Immune Cells as a Possible Source of New Therapeutic Approaches in Autoimmunity |
Review essay (rassegna critica) |
Vai |
2020 |
Colchicine as possible treatment of non-cryoglobulinaemic vasculitis in Sjögren's syndrome |
Lettera |
Vai |